Literature DB >> 15088118

Parvovirus B19-induced multisystem disease simulating systemic vasculitis in a young child.

Rashna Dass1, P Ramesh, R K Ratho, Akshay Kumar Saxena, Surjit Singh.   

Abstract

Parvovirus B19 mostly presents as a transient viral illness or as pure red cell aplasia. However, this virus can sometimes cause an illness that may pose diagnostic difficulties. We describe one such patient who had clinical features simulating a vasculitic disorder secondary to parvovirus B19 infection.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15088118     DOI： 10.1007/s00296-004-0465-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   3.580


  17 in total

1.  Parvovirus B19 infection associated with respiratory distress.

Authors:  C N Morris; J D Smilack
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

2.  Parvovirus B19-associated transient pure red cell aplasia with lymphadenopathy: a case report.

Authors:  Y Sadahira; S Yoshimoto; T Manabe
Journal:  Pathol Int       Date:  1998-10       Impact factor: 2.534

Review 3.  Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis.

Authors:  A Bousvaros; R Sundel; G M Thorne; K McIntosh; M Cohen; D D Erdman; A Perez-Atayde; T H Finkel; A A Colin
Journal:  Pediatr Pulmonol       Date:  1998-11

4.  The spectrum of renal disease associated with microscopic polyangiitis and classic polyarteritis nodosa in Kuwait.

Authors:  K el-Reshaid; M M Kapoor; W el-Reshaid; J P Madda; J Varro
Journal:  Nephrol Dial Transplant       Date:  1997-09       Impact factor: 5.992

5.  Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis.

Authors:  S Tanawattanacharoen; R J Falk; J C Jennette; J B Kopp
Journal:  Am J Kidney Dis       Date:  2000-06       Impact factor: 8.860

6.  Acute glomerulonephritis after human parvovirus B19 infection.

Authors:  T Nakazawa; N Tomosugi; K Sakamoto; M Asaka; T Yuri; I Ishikawa; S Kitagawa
Journal:  Am J Kidney Dis       Date:  2000-06       Impact factor: 8.860

7.  Endocapillary proliferative glomerulonephritis in a patient with parvovirus B19 infection.

Authors:  A Komatsuda; H Ohtani; T Nimura; A Yamaguchi; H Wakui; H Imai; A B Miura
Journal:  Am J Kidney Dis       Date:  2000-10       Impact factor: 8.860

8.  Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy.

Authors:  A Moudgil; C C Nast; A Bagga; L Wei; A Nurmamet; A H Cohen; S C Jordan; M Toyoda
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

Review 9.  Association of parvovirus B19 infection with acute glomerulonephritis in healthy adults: case report and review of the literature.

Authors:  Y Mori; H Yamashita; Y Umeda; Y Uchiyama-Tanaka; A Nose; N Kishimoto; Y Kijima; T Nagata; M Mori; H Matsubara; H Yoshida; T Iwasaka
Journal:  Clin Nephrol       Date:  2002-01       Impact factor: 0.975

10.  Human parvovirus B19-associated arthritis in children.

Authors:  J J Nocton; L C Miller; L B Tucker; J G Schaller
Journal:  J Pediatr       Date:  1993-02       Impact factor: 4.406
View more
  3 in total

1.  Phantom cytomegalovirus infection in vasculitis patients: what it means and what to do.

Authors:  Konstantinos H Katsanos; Aggeliki Kostoula; Konstantinos P Katopodis; Kostas C Siamopoulos
Journal:  Rheumatol Int       Date:  2004-10-16       Impact factor: 2.631

Review 2.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Parvovirus leading to thrombotic microangiopathy in a healthy adult.

Authors:  Bhanu Prasad; Jennifer St Onge
Journal:  BMJ Case Rep       Date:  2016-01-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.